Key considerations for health plan sponsors in covering family-building benefits (including in vitro fertilization (IVF)) ...
February 18, 2026 - PRESSADVANTAGE - Estate planning firm Sawyer & Sawyer, P.A. has released a new educational ...
A Japanese macaque named Punch has gone viral. A biologist explains how his journey from abandonment to social integration ...
The Simpsons' deep exploration into supporting characters allows the show to have an unmatched longevity compared to other ...
Home > Press release: Long-term safety forecasting for nuclear ...
In exploring barriers in rare disease research and drug development, experts highlight a lack of robust models, limited trial populations, fragmented global expectations, and production bottlenecks as ...
In an interview, C. Ola Landgren, MD, PhD, delved into the details of the FDA's draft guidance on using MRD as a basis for ...
Last week, the FDA made its one pivotal trial policy official, sparking myriad questions from industry leaders, including around specific evidence required for the single study and why it hasn’t been ...
Disc Medicine stock is hit by an FDA CRL for bitopertin. Learn key trial risks, cash runway, and why APOLLO Phase 3 results in 4Q26 matter.
A steady stream of ultra-high-net-worth individuals is deciding to hightail it to new countries. Here's where they're headed.
Health chief Robert F. Kennedy Jr. is on tour to tout his MAHA food initiatives and drug pricing over vaccines, an issue GOP pollsters see as a liability.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results